| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $6.59M | - | |
| Dir | 416.5K | $6.27M | - | |
| VP | 347.7K | $5.23M | - | |
| Other | 174.5K | $2.63M | - | |
| Other | 163.8K | $2.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2017 | Palti Yoram | Chief Technology Officer | Sell | 60,000 | $21.72 | $1,303,200.00 | -1.8% | |
| Nov 3, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 3,400 | $22.00 | $74,800.00 | -4.2% | |
| Nov 1, 2017 | Kirson Eilon D. | Chief Science Officer | Sell | 22,269 | $22.01 | $490,110.44 | -17.6% | |
| Nov 1, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 15,866 | $22.01 | $349,169.87 | -1.0% | |
| Nov 1, 2017 | Ambrogi Michael J. | Chief Operating Officer | Sell | 24,327 | $22.01 | $535,363.59 | -24.5% | |
| Sep 25, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 900 | $22.05 | $19,845.00 | -0.1% | |
| Sep 14, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 37,272 | $22.01 | $820,502.30 | -2.3% | |
| Jul 11, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 7,383 | $19.95 | $147,324.77 | -0.8% | |
| Jul 10, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 274,359 | $18.07 | $4,956,557.91 | -19.5% | |
| Jul 6, 2017 | Danziger Asaf61 | Chief Executive Officer | Sell | 160,138 | $18.14 | $2,905,261.07 | -9.7% |